
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES212
The same study found a moderate, though significant, benefit associated with clopidogrel plus aspirin as compared with placebo plus aspirin in reducing the secondary composite endpoint of MI, stroke, or death from CV causes, or hospitalisation for unstable angina, transient ischemic attack or revascularisation (see table 15.2). Level 1++

[@Bhatt_2006]

